DENTAL PRACTICE LOANS: NO ADVANCE PAYMENT NEEDED – More Info Click Here!

Call: 904-551-6090

Smart practitioners are saving hundreds if not thousands of dollars per month by Debt Consolidation of their personal and business loans. Interest rates are still low enough to cash in on this now! A Medical Practice Debt Consolidation Loan is the way to help your Practice get out of debt and into profits.

If you are looking to expand your medical practice, many practitioners are reinvesting their savings back into their business. Often that investment takes the form of increased spending on a medical practice marketing consultant.

Burdened with a busy schedule and now armed with extra cash, medical practitioners mistakenly initiate medical practice marketing projects without a budget or plan. These practitioners may end up with an impressive new website or creative direct mail campaigns, without seeing any significant increase in their bottom line. Here is a way to stay ahead of the game!

Gilead Revenue Soars on Hepatitis C Drug

– http://www.nytimes.com

Gilead Sciences reported $2.3 billion in sales of Sovaldi, a new hepatitis C drug that has raised an outcry over its $1,000-a-pill price.

Continue Reading On http://www.nytimes.com »

Well: The Limits of ‘No Pain, No Gain’

– http://www.nytimes.com

A new study helps to explain why exercise makes our muscles ache, and suggests that it’s not always a good idea to ignore fatigue and push on.

Continue Reading On http://www.nytimes.com »

World Briefing: Ebola Outbreak in West Africa Kills Over 140, U.N. Agency Says

– http://www.nytimes.com

The World Health Organization said on Tuesday that at least 230 suspected or confirmed cases of Ebola had been recorded in Guinea and Liberia.

Continue Reading On http://www.nytimes.com »

Economic Scene: Acceleration Is Forecast for Spending on Health

– http://www.nytimes.com

The Affordable Care Act may well be on track to meeting its primary goal, but reining in health care spending still appears well beyond the grasp of the law.

Continue Reading On http://www.nytimes.com »

DealBook: Seeking the Right Chemistry, Drug Makers Hunt for Mergers

– http://www.nytimes.com

The offer for Allergan by William A. Ackman and Valeant Pharmaceuticals marks an unusual pairing of activist investor and corporate buyer that could reshape the deal landscape.